Studies on the role of NS3 and NS5A non-structural genes of hepatitis C virus genotype 3a local isolates in apoptosis

International Journal of Infectious Diseases

Volumn 25, Issue , 2014, Pages 38-44

  Sabri, Sabeen ^a   Idrees, Muhammad ^a   Rafique, Shazia ^b   Ali, Amjad ^c   Iqbal, Muhammad ^b  

^a UNIVERSITY OF THE PUNJAB   (Pakistan)

^b MINISTRY OF SCIENCE AND TECHNOLOGY   (Pakistan)

^c UNIVERSITY OF MALAKAND   (Pakistan)

Author keywords

HCC; Hepatitis C virus; Huh 7 cell lines; Liver cirrhoses; Non structural proteins; P53 gene

Indexed keywords

NONSTRUCTURAL PROTEIN 3; NONSTRUCTURAL PROTEIN 5A; PROTEIN P53; MESSENGER RNA; NS-5 PROTEIN, HEPATITIS C VIRUS; NS3 PROTEIN, HEPATITIS C VIRUS; PROTEIN BINDING; VIRUS PROTEIN; VIRUS RNA;

APOPTOSIS; ARTICLE; DOWN REGULATION; GENE EXPRESSION; GENETIC TRANSFECTION; GENOTYPE; HEPATITIS C VIRUS; HUMAN; HUMAN CELL; IMMUNOFLUORESCENCE TEST; LIVER CARCINOGENESIS; NONHUMAN; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; VIRUS GENE; WESTERN BLOTTING; CELL CULTURE; CELL LINE; GENE ORDER; GENE VECTOR; GENETICS; HEPACIVIRUS; HEPATITIS C; METABOLISM; PROTEIN TRANSPORT; VIROLOGY;

APOPTOSIS; CELL LINE; CELLS, CULTURED; GENE EXPRESSION; GENE ORDER; GENETIC VECTORS; GENOTYPE; HEPACIVIRUS; HEPATITIS C, CHRONIC; HUMANS; PROTEIN BINDING; PROTEIN TRANSPORT; RNA, MESSENGER; RNA, VIRAL; TRANSFECTION; TUMOR SUPPRESSOR PROTEIN P53; VIRAL NONSTRUCTURAL PROTEINS;

EID: 84901987072     PISSN: 12019712     EISSN: 18783511     Source Type: Journal    
DOI: 10.1016/j.ijid.2014.01.010     Document Type: Article

References (41)

1. Choo Q.L., Kuo G., Weiner A.J., Overby L.R., Bradley D.W., Houghton M. Isolation of a cDNA clone derived from a blood-borne non-A, non-B viral hepatitis genome. Science 1989, 244:359-362.
2. Major M.E., Feinstone S.M. The molecular virology of hepatitis C. Hepatology 1997, 25:1527-1538.
3. Chayama K., Hayes C.N. Hepatitis C virus: how genetic variability affects pathobiology of disease. J Gastroenterol Hepatol 2011, 26:83-95.
4. Rehermann B. Hepatitis C virus versus innate and adaptive immune responses: a tale of coevolution and coexistence. J Clin Invest 2009, 119:1745-1754.
5. Guo J., Yan R., Xu G., Zheng C. HCV NS5A and NS5B enhance expression of human ceramide glucosyltransferase gene. Virol Sin 2012, 27:38-47.
6. Shiryaev S.A., Thomsen E.R., Cieplak P., Chudin E., Cheltsov A.V., Chee M.S., et al. New details of HCV NS3/4A proteinase functionality revealed by a high-throughput cleavage assay. PLoS One 2012, 7:e35759.
7. Wang W., Lahser F.C., Yi M.K., Wright-Minogue J., Xia E., Weber P.C., et al. Conserved C-terminal threonine of hepatitis C virus NS3 regulates autoproteolysis and prevents product inhibition. J Virol 2004, 78:700-709.
8. Burlone M.E., Budkowska A. Hepatitis C virus cell entry: role of lipoproteins and cellular receptors. J Gen Virol 2009, 90:1055-1070.
9. Iwai A., Takegami T., Shiozaki T., Miyazaki T. Hepatitis C virus NS3 protein can activate the notch-signaling pathway through binding to a transcription factor. SRCAP. PLoS One 2011, 6:207-218.
10. Gupte G.M., Arankalle V.A. Evaluation of the immunogenicity of liposome encapsulated HVR1 and NS3 regions of genotype 3 HCV, either singly or in combination. J Virol 2012, 9:74.
11. Shimakami T., Hijikata M., Luo H., Yuan Ma Y., Kaneko S., Shimotohno K., et al. Effect of interaction between hepatitis C virus NS5A and NS5B on hepatitis C virus RNA replication with the hepatitis C virus replicon. J Virol 2004, 78:2738-2748.
12. Lan K., Sheu M., Hwang S., Yen S., Chen S., Wu J., et al. HCV NS5A interacts with p53 and inhibits p53-mediated apoptosis. Oncogene 2002, 21:4801-4811.
13. Kane M., Golovkina T. Common threads in persistent viral infections. J Virol 2010, 84:4116-4123.
14. Lin J., Chen J., Elenbaas B., Levine A.J. Several hydrophobic amino acids in the p53 amino-terminal domain are required for transcriptional activation, binding to mdm-2 and the adenovirus 5 E1B 55-kD protein. Genes Dev 1994, 8:1235-1246.
15. Anzola M. Hepatocellular carcinoma: role of hepatitis proteins: hepatitis C infection and hepatocarcinogenesis. J Viral Hepat 2004, 11:383-393.
16. Song H., Li J., Shi S., Yan L., Zhuang H., Li K. Thermal stability and inactivation of hepatitis C virus grown in cell culture. J Virol 2010, 7:40.
17. Kasprzak A., Adamek A. Role of hepatitis C virus proteins (C, NS3, NS5A) in hepatic oncogenesis. Hepat Res 2008, 38:1-26.
18. Kasprzak A., Adamek A., Przybyszewska W., Olejniczak K., Biczysko W., Mozer-Lisewska I., et al. p21/Wafl/Ciplcellular expression in chronic long-lasting hepatitis C: correlation with HCV proteins (C, NS3, NS5A), other cell-cycle related proteins and selected clinical data. Folia Histochem Cytobiol 2009, 47:385-394.
19. Koike K., Tsutsumi T., Miyoshi H., Shinzawa S., Shintani Y., Fujie H., et al. Molecular basis for the synergy between alcohol and hepatitis C virus in hepatocarcinogenesis. J Gastroenterol Hepatol 2008, 23:87-91.
20. Bigger C., Brasky M., Lanford R.E. DNA microarray analysis of chimpanzee liver during acute resolving hepatitis C virus infection. J Virol 2001, 75:7059-7066.
21. Bigger C.B., Guerra B., Brasky K.M., Hubbard G., Beard M.R., Luxon B.A., et al. Intrahepatic gene expression during chronic hepatitis C virus infection in chimpanzees. J Virol 2004, 78:13779-13792.
22. Blight K.J., McKeating J.A., Marcotrigiano J., Rice C.M. Highly permissive cell lines for sub genomic and genomic hepatitis C RNA replication. J Virol 2002, 76:13001-13014.
23. Cooper S., Erickson A.L., Adams E.J., Kansopon J., Weiner A.J., Chien D.Y., et al. Analysis of a successful immune response against hepatitis C virus. Immunity 1999, 10:439-449.
24. Kato T., Date T., Murayama A., Morikawa K., Akazawa D., Wakita T. Cell culture and infection system for hepatitis C virus. Nat Protoc 2006, 1:2334-2339.
25. Wakita T., Kato T. Development of an infectious HCV cell culture system. Hepatitis C virus: genomes and molecular biology. Hepatitis C Viruses: Genomes and Molecular Biology 2006, Horizon Biosciences, Norfolk (UK), PMID: 21250389. NBK1626 [Chapter 16]. S.L. Tan (Ed.).
26. Blight K.J., Kolykhalov A.A., Rice C.M. Efficient replication of HCV RNA replication in cell culture. Science 2000, 290:1972-1974.
27. Hu Y.W., Rocheleau L., Larke B., Chui L., Lee B., Ma M., et al. Immunoglobulin mimicry by hepatitis C virus envelope protein E2. Virology 2005, 332:538-549.
28. Butt S., Idrees M., Rehman I., Ali L., Hussain A., Ali M., et al. Establishment of stable Huh-7 cell lines expressing various hepatitis C virus genotype 3a protein: an in-vitro testing system for novel anti-HCV drugs. Genet Vaccines Ther 2011, 9:12.
29. Chen S., Wang Y.M. Evolutionary study of hepatitis C virus envelope genes during primary infection. Chin Med J 2007, 120:2174-2180.
30. Karmochkine M., Carrat F., Dos-Santos O., Cacoub P., Raguin G. A case-control study of risk factors for hepatitis C infection in patients with unexplained routes of infection. J. Viral Hepat 2006, 13:775-782.
31. Lemon S.M., Walker C.M., Alter M.J., Yi M. Hepatitis C virus. Fields virology 2007, 1253-1304. Lippincott Williams and Wilkins, Philadelphia, PA. D.M. Knipe, P.M. Howley (Eds.).
32. Lindenbach B., Rice C. Unravelling hepatitis C virus replication from genome to function. Nature 2005, 436:933-938.
33. Lohmann V., Korner F., Koch J., Herian U., Theilmann L., Bartenschlager R. Replication of subgenomic hepatitis C virus RNA in hepatoma cell line. Science 1999, 285:110-113.
34. Bartenschlager R., Pietschmann T. Efficient hepatitis C virus cell culture system: what a difference the host cell makes. Proc Natl Acad Sci U S A 2005, 102:9739-9740.
35. Morikawa K., Lange C.M., Gouttenoire J., Meylan E., Brass V., Penin F. Nonstructural protein 3-4A: the Swiss army knife of hepatitis C virus. J Viral Hepat 2011, 18:305-315.
36. Liao W., Tung S., Shen C., Lee K., Wu C. Tissue expression of the hepatitis C virus NS3 protein does not correlate with histological or clinical features in patients with chronic hepatitis C. Chang Gung Med J 2011, 34:260-267.
37. Liew M., Erali M., Page S., Hillyard D., Wittwer C. Hepatitis C genotyping by denaturing high-performance liquid chromatography. J Clin Microbiol 2004, 42:158-163.
38. Amaral J.D., Xavier J.M., Steer C.J., Rodrigues C.M. The role of p53 in apoptosis. Discov Med 2010, 9:145-152.
39. Brown C.J., Lain S., Verma C.S., Fersht A.R., Lane D.P. Awakening guardian angels: drugging the p53 pathway. Nat Rev Cancer 2009, 9:862-873.
40. Majumder M., Ghosh A.K., Steele R., Ray R., Ray R.B. Hepatitis C virus NS5A physically associates with p53 and regulates p21/waf1 gene expression in a p53-dependent manner. J Virol 2001, 75:1401-1407.
41. Deng L., Fujii M.N., Tanaka M., Takigawa Y.N., Ikeda M., Kato N., et al. NS3 protein of hepatitis C virus associates with the tumour suppressor p53 and inhibits its function in an NS3 sequence-dependent manner. J Gen Virol 2006, 87:1703-1713.